Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).
DOI: 10.1200/jco.2021.39.3_suppl.335
文献链接: https://ascopubs.org/doi/10.1200/JCO.2021.39.3_suppl.335
其他信息:
出版社: American Society of Clinical Oncology (ASCO)
作者: Mark Yarchoan; Qingfeng Zhu; Jennifer N. Durham; Nicole Gross; Soren Charmsaz; James M. Leatherman; Shu Zhang; Aleksandra Popovic; Matthew John Weiss; Benjamin Philosophe; Richard A. Burkhart; William Burns; Brad Wilt; Elizabeth Sugar; Elana J. Fertig; Dan Laheru; Robert A Anders; Elizabeth M. Jaffee; Won Jin Ho

